http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#Head http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#assertion http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#provenance http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#pubInfo http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#assertion http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#assertion http://www.w3.org/ns/prov#wasGeneratedBy S&T TWOC project version 1 http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#version http://www.w3.org/ns/prov#value 1 http://www.w3.org/1999/02/22-rdf-syntax-ns#object https://uts.nlm.nih.gov/uts/umls/concept/C1609165 tocilizumab http://www.w3.org/1999/02/22-rdf-syntax-ns#object https://uts.nlm.nih.gov/uts/umls/concept/C1609931 siltuximab http://www.w3.org/1999/02/22-rdf-syntax-ns#object https://uts.nlm.nih.gov/uts/umls/concept/C3885145 sarilumab http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=TRIPLE_UID:swcqhjom-TRIPLE-ABSTRACT-5 include http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C0001617 corticosteroids http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C0011777 dexamethasone http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C0021760 IL-6 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C0243077 inhibitors http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C1149241 IL-6 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C1334122 IL-6 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C1527132 IL-6 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C1698754 IL-6 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C2983957 IL-6 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C3539185 corticosteroids http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C3540725 corticosteroids http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C3540726 corticosteroids http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C3540727 corticosteroids http://www.w3.org/2000/01/rdf-schema#Triple-UID http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:swcqhjom-TRIPLE-ABSTRACT-5 swcqhjom-TRIPLE-ABSTRACT-5 http://www.w3.org/2000/01/rdf-schema#sentence http://www.w3.org/2000/01/rdf-schema#label Currently, there are FDA-approved therapies that attenuate the dysregulated inflammation that occurs in COVID-19 patients, such as dexamethasone or other corticosteroids and IL-6 inhibitors, including sarilumab, tocilizumab, and siltuximab. http://www.w3.org/2000/01/rdf-schema#triple http://www.w3.org/2000/01/rdf-schema#label dexamethasone or other corticosteroids and IL-6 inhibitors including sarilumab , tocilizumab , and siltuximab http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#provenance http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#assertion http://www.w3.org/ns/prov#generatedAtTime 2021-07-25T21:46:14.949682 http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#pubInfo http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#sig http://purl.org/nanopub/x/hasSignature T4Tj08g182QZFmw96+spP6sStDsr12QaEMSnYT1hHtRavTWki8ZjVnbeHC6XLB3yzGdHodxLs6Xv4QS7QeklKMOyV9bd+4drm3HuIdDCNpQnlvT+MPOoGkkd5hdAWaQYrFrT0t22NxTQI2/zwZ6BPxu2Ys1UO2O4TecndriGHbM= http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI http://www.w3.org/ns/prov#generatedAtTime 2021-07-25T21:46:14.949682 http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-8954-0470